Two-dimensional (2D) liquid chromatography (2DLC) methods have grown in popularity due to their enhanced peak capacity that allows for resolving complex samples. Given the large number of commercially available column types, one of the major challenges in implementing 2DLC methods is the selection of suitable column pairs. Column selection is typically informed by chemical intuition with subsequent experimental optimization. In this work a computational screening method for 2DLC is proposed whereby virtual 2D chromatograms are calculated utilizing the Snyder-Dolan hydrophobic subtraction model (HSM) for reversed-phase column selectivity. Towards this end, 319 225 column pairs resulting from the combination of 565 columns and 100 sets of 1000 diverse analytes are examined. Compared to other screening approaches, the present method is highly predictive for column pairs that are able to resolve the largest number of analytes. This approach shows a strong sensitivity to the choice of the second dimension column (having a shorter operating time) and a preference for those with embedded polar moieties, whereas a relatively weak preference for C and phenyl columns is found for the first dimension.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chroma.2018.09.018 | DOI Listing |
J Chromatogr A
December 2024
Department of Chemical Engineering, University College London, Torrington Place, London, WC1E 7JE, UK. Electronic address:
To elevate the separation performance, two-dimensional liquid chromatography (2D-LC) uses two chromatographic columns with different stationary phases to diversify solute interactions with the resin, hence providing a second "dimension" to solute-specific separation. Developing methods for 2D-LC starts therefore with preliminary column selection. Selecting columns that yield (metaphorically) orthogonal dimensions is of utmost importance, but remains challenging.
View Article and Find Full Text PDFJ Pharm Sci
December 2024
Therapeutics Development & Supply, Janssen Research & Development, NV, a Johnson & Johnson company, Beerse, Belgium.
Small interfering RNAs (siRNAs) have emerged as a highly promising class of therapeutics, capable of effectively treating a wide range of indications, including previously challenging targets. To correctly characterize the duplex content of siRNA therapeutics, a careful design of the analytical conditions is required. This is due to the weak interactions governing the duplex formation and thermal stability of these double-stranded oligonucleotides.
View Article and Find Full Text PDFEJNMMI Radiopharm Chem
December 2024
Department of Radiology, University of Alabama at Birmingham, 1824 6th Ave. S., Birmingham, AL, 35294, USA.
Background: Scandium-47 is the therapeutic counterpart to the diagnostic radionuclides, Sc and Sc. Together, these form elementally matched theranostic nuclide pairs, but their incorporation into radiopharmaceuticals requires developing production techniques leading to radioscandium isotopes with high chemical and radionuclidic purity. Previous Sc production methods involved expensive, enriched titanium targets that require additional procedures for target recovery.
View Article and Find Full Text PDFOrthop Surg
December 2024
Department of Orthopedics, The Fourth Medical Center of PLA General Hospital, Beijing, China.
Objective: Surgery to correct the cervicothoracic kyphotic deformity in ankylosing spondylitis (AS) can be associated with serious neurovascular risks. According to the literature, there are no clinical reports documenting the use of vertebral column decancellation (VCD) in the treatment of cervicothoracic kyphotic deformity in patients with AS. The purpose of the present study was to retrospectively analyze and evaluate the effect of VCD on cervicothoracic kyphotic deformity in patients with AS.
View Article and Find Full Text PDFJ Chromatogr A
January 2025
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel Servet 1, 1211, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Electronic address:
The rapid development of mRNA-based therapeutics, especially post-COVID-19, has necessitated the precise characterization of mRNA quality attributes, including sequence integrity. Ion-pairing reversed-phase liquid chromatography (IP-RPLC) has been widely accepted as a reference method for the characterization of small oligonucleotides. Some studies have already investigated the use of IP-RPLC for RNA, but no systematic approach has been developed to assess the impact of ion-pairing agents (IPAs) on the separation of large RNA molecules.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!